Yes you right , but leronlimab will work for every group , moderate , severe , critical , and often very fast , drug removing in one day many from the ventilators and in few days from ECMO..
Apparently they see some patients not responding to leronlimab , but very few , hopefully by evaluating biomarkers they will find a reason for it ..
imo.